4 hrs ago | WAFB-TV Baton Rouge
Pfizer gets FDA approval for intravenous Revatio
Drug developer Pfizer Inc. said Friday the Food and Drug Administration approved an intravenous version of its high blood pressure drug Revatio.
8 hrs ago | Medical News
Ligand Pharmaceuticals receives $2 million in milestone payments from N. V. Organon
Ligand Pharmaceuticals Incorporated announced today that it has received $2 million in milestone payments from N. V. Organon, a subsidiary of Merck & Co., Inc., stemming from its research collaboration that is due to expire at the end of December.
12 hrs ago | BioSpace
PPD, Inc. to Acquire BioDuro, LLC
PPD, Inc. today announced it has signed an agreement to acquire BioDuro LLC, a drug discovery outsourcing company that provides a broad range of integrated services to biopharmaceutical companies.
16 hrs ago | Bioscience Technology
OraSure settles HIV test patent lawsuit
OraSure Technologies Inc., which makes diagnostic kits to detect HIV and drug use, said Thursday it will pay Inverness Medical $3 million to settle a patent dispute over HIV tests.
The Botax? Nip/tuck levy to help health care plan
In this Nov. 29, 2006 file photo, Dr. Jeffrey M. Kenkel gives patient Amy Andrade a Botox treatment at his office in the Northpark Mall in Dallas.
Ex-drug distributor chairman convicted of fraud
A federal jury on Thursday found the former head of the country's largest drug distributor guilty of fraud, nearly 10 years after he played a central role in one of the costliest corporate accounting scandals of the time.
US survey shows Southern counties most obese
The first county-by-county survey of obesity reflects past studies that show the rate of obesity is highest in the Southeast and Appalachia.
Santa Wants On H1N1 Vaccine Priority List
Santa pleads with the Centers for Disease Control and Prevention to add him to the H1N1 vaccine priority list.
Quest Diagnostics buying back senior notes
Medical lab operator Quest Diagnostics Inc. said Tuesday it priced its tender offer to buy back a mix of senior notes.
"Geezer Bandit" hits 5 banks, becoming more brazen
Three rewards totaling $16,000 were on offer today for information leading to the arrest and conviction of the "Geezer Bandit," a retirement-age robber responsible for armed holdups at five San Diego-area banks since summer.
Judges: Seattle biotech can pursue $23M claim
Seattle biotechnology firm Cell Therapeutics Inc. can pursue claims for nearly $23 million against a former consultant, a federal appeals court ruled Wednesday.
FDA Panel Backs Pfizer's Enhanced Vaccine for Kids
FILE - In this Jan. 25, 2009 file photo, a sign at Pfizer world headquarters in New York is shown.... FILE - In this Jan.
Rival: ED drug faster than Viagra, Lilly's Cialis
A drug being developed by a California company was shown in a trial to be effective in 30 minutes or less, much faster than its competitors, the maker of treatments for erectile dysfunctions said today.
Home sales in Riverside County fell by 9.1 percent in October, compared to last year
Home sales in Riverside County fell by 9.1 percent in October, compared to the same month a year ago, while prices fell by 17.4 percent, a real estate information service reported today.
BioCryst Pharma to sell up to 5.75M new shares
Flu drug developer BioCryst Pharmaceuticals Inc. said Tuesday it plans to sell as many as 5.75 million new shares of stock.
FBI seeks 'Geezer Bandit' in Calif. bank robberies
FBI officials say an elderly, thin, gray-haired man nicknamed the "Geezer Bandit" is responsible for holding up five San Diego-area banks since summer.
Vaccines on horizon for AIDS, Alzheimer's, herpes
Malaria. Tuberculosis. Alzheimer's disease. AIDS. Pandemic flu. Genital herpes. Urinary tract infections.
FDA warns that heartburn drug Prilosec can block benefits of blood thinner Plavix
Federal health officials said Tuesday a popular heartburn medication can interfere with the blood thinner Plavix, a drug taken by millions of Americans to reduce risks of heart attack and stroke.
Novartis: Lower vaccine dose sufficient
Pharmaceutical maker Novartis AG said Tuesday a U.S. clinical study suggests that half a dose of its swine flu vaccine may be sufficient to protect people from the virus and could allow many more to be immunized with current supplies.
Alkermes higher on Vivitrol optimism
New patients must get a screening blood test for Vivitrol. Cambridge-based Alkermes Inc.
Also on Topix